Primary Results of the VHD-W (Valvular Heart Disease in Women) Study

31 August 2026 (14:15 - 14:30)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Julia Grapsa

Brigham and Women's Hospital, Heart and Vascular Center, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail

Medium-term outcomes following contemporary transcatheter aortic valve implantation in England: insights from national registry linkage

Professor R. Kharbanda (Oxford, GB)

Presentation thumbnail

Isolated Tricuspid Valve Replacement at 20-Year Follow-up. Insight from the largest multicenter international registry. DURABLE Tricuspid

Doctor E. Zancanaro (Mainz, DE)

Presentation thumbnail

How Much Tricuspid Regurgitation Reduction Is Enough? Residual TR and Long-Term Outcomes After T-TEER in the Randomized TRI-FR Extension

Professor E. Donal (Rennes, FR)

Access the full session

Session thumbnail

Valvular heart disease: lessons from real-world practice

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET

You may be interested in

Congress Presentation

Sex related differences in frequency, management and outcome of severe native valvular heart disease. Results from the ESC-EORP Valvular Heart Disease II survey

30 August 2024

Congress Presentation

Diagnosing Laennec’s chest conditions: technology advances to address an epidemic of cardiovascular death in women

30 August 2026

Congress Presentation

Addressing underdiagnosis in women with aortic stenosis

31 August 2024

Congress Session

Late-Breaking Clinical Science: cardiovascular health in women

31 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources